Delivery Order SPE2DB20D3303-SPE2DB25FZ1D8

Award Date 2/18/25
Potential Completion Date 2/19/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S. The order has a ceiling value of $1,171.36 and a completion date of March 8, 2024. The contract is a Firm Fixed Price arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,478.23 firm fixed-price delivery order is for TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, with a period of performance through January 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,036.57, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a pharmaceutical product, with a completion date of January 29, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $4,551.15 and is a delivery order with a firm fixed price pricing type. The contract is for the supply of 4566874633 ! TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, with an ultimate completion date of January 9, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 capsules of Tamsulosin HCL 0.4 mg. The contract has a ceiling value of $1,326.16 and a completion date of October 31, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,959.15 firm-fixed-price delivery order is for the supply of 1,000 units of the drug Tamsulosin HCl 0.4 mg capsules, with a completion date of April 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,824.30, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, with a completion date of February 2, 2024. This is a firm fixed price Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,267.04 firm fixed-price delivery order contract is for the supply of 4,566,690,189 units of the prescription medication Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,017.39, is for the delivery of 1,000 units of the generic drug Tamsulosin Hydrochloride 0.4 mg capsules. The contract has an ultimate completion date of November 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,096.99, is for the delivery of 4,567,327,770 units of Tamsulosin HCL 0.4 mg capsules. The contract is a firm fixed-price delivery order with a completion date of February 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB25FZ1D8
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S. The order has a firm fixed price of $1,256.22 and a completion date of February 19, 2025. The contract is not designated with a set-aside.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/20/25, 1:45 PM